Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Ethereum showcased explosive bullish momentum with institutional demand accelerating through spot ETFs while shattering ...

The top 100 addresses increased their holdings by 2.3% over the past month, while exchange holdings have dropped by 2.17%.

The move higher in Filecoin came amid an explosive rally in crypto markets, with the broader market gauge, the Coindesk 20, recently up 7%. Bitcoin BTC $110,770.05 , the world's largest cryptocurrency ...

Despite the launch of a NEAR ETP, the token faces significant selling pressure amid broader market uncertainty.

Advancements in B-cell therapies, including anti-CD20 and anti-CD19 monoclonal antibodies, enhance treatment efficacy and safety for multiple sclerosis and autoimmune diseases.

AbelZeta Announces Promising Long-Term Outcomes for C-CAR039, a Novel CD19/CD20 Bi-Specific CAR-T Therapy, in Patients with R/R B NHL at EHA 2025 ...

Following this recommendation, Bio-Thera has decided to close patient enrollment ahead of schedule. BAT4406F is an ADCC-enhanced, fully humanized anti-CD20 monoclonal antibody developed by Bio-Thera.

Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

TG Therapeutics sees growth from BRIUMVI’s MS launch, but competition, pipeline risks, and valuation concerns limit upside.

Panelist discusses how Bruton tyrosine kinase inhibitors fit into real-world practice with community physicians often using monotherapy, while emphasizing the importance of specialist knowledge to ...